Creative Medical Technology Holdings, Inc.
CELZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $6 | $4 | $6 |
| - Cash | $6 | $3 | $8 | $11 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$3 | $3 | -$4 | -$5 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 22.2% | -89.8% | 1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 60% | 60% | 67.8% | 45.4% |
| EBITDA | -$6 | -$6 | -$10 | $24 |
| % Margin | -51,212.8% | -61,395% | -11,458.6% | 26,873.2% |
| Net Income | -$5 | -$5 | -$10 | $19 |
| % Margin | -49,940.7% | -58,739.7% | -11,449.3% | 21,892.8% |
| EPS Diluted | -3.71 | -3.76 | -9.28 | 56.1 |
| % Growth | 1.3% | 59.5% | -116.5% | – |
| Operating Cash Flow | -$5 | -$8 | -$8 | -$2 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$5 | -$8 | -$8 | -$2 |